Major depression as a disorder of serotonin resistance: Inference from diabetes mellitus type II

International Journal of Neuropsychopharmacology

Volumn 10, Issue 6, 2007, Pages 839-850

  Smolin, Bella ^a   Klein, Ehud ^a   Levy, Yishai ^a   Ben Shachar, Dorit ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Depression; Diabetes type II; Serotonin resistance

Indexed keywords

ANTIDEPRESSANT AGENT; NORADRENALIN; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SULFACARBAMIDE;

CENTRAL NERVOUS SYSTEM DISEASE; HUMAN; HYPERINSULINEMIA; HYPERSEROTONISM; INSULIN RESISTANCE; MAJOR DEPRESSION; MENTAL STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEROTONIN RESISTANCE;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS, TYPE 2; HUMANS; NOREPINEPHRINE; SEROTONIN; STRESS, PSYCHOLOGICAL;

EID: 35648981829     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145707007559     Document Type: Review

References (100)

1. Adell A, Casanovas JM, Artigas F (1997). Comparative study in the rat of the actions of different types stress on the release of 5-HT in raphe nuclei and forebrain. Neuropharmacology 36, 735-741.
2. Arango V, Underwood MD, Gubbi AV, Mann JJ (1995). Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Research 688, 121-133.
3. Arias B, Catalan R, Gasto C, Gutierrez B, Fananas L (2003). 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. Journal of Clinical Psychopharmacology 23, 563-567.
4. Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J (1994). Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biological Psychiatry 35, 457-463.
5. Asberg M, Bertilsson L, Martensson B, Scalia-Tomba GP, Thoren P, Traskman-Bendz L (1984). CSF monoamine metabolites in melancholia. Acta Psychiatrica Scandinavica 69, 201-219.
6. Austin MC, Whitehead RE, Edgar CL, Janosky JE, Lewis DA (2002). Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide. Neuroscience 114, 807-815.
7. Badamgarav E, Weingarten SR, Henning JM, Knight K, Hasselblad V, Gano Jr. A, Ofman JJ (2003). Effectiveness of disease management programs in depression: a systematic review. American Journal of Psychiatry 160, 2080-2082.
8. 11C]WAY-100635. Archives of General Psychiatry 62, 1032-1041.
9. Baraban JM, Aghajanian GK (1980). Supression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19, 355-363.
10. Bergman RN, Zaccaro DJ, Watanabe RM, Haffner SM, Saad MF, Norris JM, Wagenknecht LE, Hokanson JE, Rotter JI, Rich SS (2003). Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin. Diabetes 52, 2168-2174.
11. 11C]WAY-100635. Molecular Psychiatry 9, 386-392.
12. Blier P, Ward NM (2003). Is there a role for 5-HT1A agonists in the treatment of depression? Biological Psychiatry 53, 193-203.
13. Blundell JE, Lawton CL, Halford JC (1995). Serotonin, eating behavior, and fat intake. Obesity Research 4, 471S-476S.
14. Boyko EJ, Keane EM, Marshall JA, Hamman RF (1991). Higher insulin and C-peptide concentrations in Hispanic population at high risk for NIDDM. San Luis Valley Diabetes Study. Diabetes 40, 509-515.
15. Caspi A, Sugden K, Moffitt T (2003). Influence of life stress on depression: moderation by a polymorphysm in the 5-HT gene. Science 301, 386-389.
16. Cheng A, Braunstein JB, Dennison C, Nass C, Blumenthal RS (2002). Reducing global risk for cardiovascular disease: using lifestyle changes and pharmacotherapy. Clinical Cardiology 25, 205-212.
17. 11C]WAY-100635. Biological Psychiatry 57, 239-246.
18. Collin M, Hakansson-Ovesjo ML, Misane I, Ogren SO, Meister B (2000). Decreased 5-HT transporter mRNA in neurons of the dorsal raphe nucleus and behavioral depression in the obese leptin-deficient ob/ob mouse. Molecular Brain Research 81, 51-61.
19. De Deurwaerdere P, Moison D, Navailles S, Porras G, Spampinato U (2005). Regionally and functionally distinct serotonin receptors control in vivo dopamine outflow in the rat nucleus accumbens. Journal of Neurochemistry 94, 140-149.
20. Dillon KA, Gros-Isseroff R, Israeli M, Biegon A (1991). Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcohol. Brain Research 554, 56-64.
21. Dinan TG (1996). Noradrenergic and serotonergic abnormalities in depression: stress-induced dysfunction? Journal of Clinical Psychiatry 57 (Suppl. 4), 14-18.
22. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C (1999). PET imaging of serotonin 1A receptor binding in depression. Biological Psychiatry 46, 1375-1387.
23. Druss BG, Rosenheck RA, Sledge WH (2000). Health and disability costs of depressive illness in a major U.S. corporation. American Journal of Psychiatry 157, 1274-1278.
24. Famularo R, Kinscheerff R, Fenton T (1992). Psychiatric diagnoses of maltreated children: preliminary findings. Journal of the American Academy of Child & Adolescent Psychiatry 31, 863-867.
25. Flugge G (1995). Dynamics of central nervous 5-HT1A-receptor under psychological stress. Journal of Neuroscience 15, 7132-7140.
26. Flugge G, Ahrens O, Fuchs E (1997). Monoamine receptors in the prefrontal cortex of Tupaia belangeri during chronic psychosocial stress. Cell and Tissue Research 288, 1-10.
27. Flugge G, Kramer M, Rensing S, Fuchs E (1998). 5-HT1A receptors and behavior under chronic stress: selective counteraction by testosterone. European Journal of Neuroscience 10, 2685-2693.
28. Flugge G, Van Kampen M, Mijnster MJ (2004). Perturbations in brain monoamine systems during stress. Cell and Tissue Research 315, 1-14.
29. Fujino K, Yoshitake T, Inoue O, Ibii N, Kehr J, Ishida J, Nohta H, Yamaguchi M (2002). Increased serotonin release in mice frontal cortex and hippocampus induced by acute physiological stressors. Neuroscience Letters 320, 91-95.
30. Funada M, Hara C (2001). Differential effects of psychological stress on activation of the hydroxytryptamine- and dopamine-containing neurons in the brain of freely moving rats. Brain Research 901, 247-251.
31. Glavin G, Tanaka M, Tsuda A, Kohno Y, Hoaki Y, Nagasaki N (1983). Regional rat brain noradrenaline turnover in response to restraint stress. Pharmacology Biochemistry & Behavior 19, 287-290.
32. Gold PW, Chousos GP (2002). Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs. low CRH/NE st. Molecular Psychiatry 7, 254-275.
33. Greenwood BN, Foley TE, Day HE, Burhans D, Brooks L, Campeau S, Fleshner M (2005). Wheel running alters serotonin (5-HT) transporter, 5-HT1A, 5-HT1B, and alpha 1b-adrenergic receptor mRNA in the rat raphe nuclei. Biological Psychiatry 57, 559-568.
34. Haffner SM, Stern MP, Dunn J, Mobley M, Blackwell J, Bergman RN (1990). Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans. Metabolism 39, 842-847.
35. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK (1986). Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. New England Journal of Medicine 315, 220-224.
36. Harris GD, White RD (2004). Lifestyle modifications for the prevention and treatment of cardiovascular disease: an evidence-based approach. Missouri Medicine in Review 101, 222-226.
37. Heim C, Nemeroff CB (2001). The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Society of Biological Psychiatry 49, 1023-1039.
38. Heisler LK, Chu HM, Brennan TJ, Danao LA, Bajwa P, Parsons LH, Tecott LH (1998). Elevated anxiety and antidepressant-like responses in 5-HT1A receptor mutant mice. Proceedings of the National Academy of Sciencs USA 95, 15049-15054.
39. Helmeste DM (1986). Rapid down-regulation of S2 serotonin receptors by antidepresant: noradrenergic-serotonergic interactions. Life Sciences 39, 223-227.
40. Himsworth H (1936). Diabetes mellitus: a differentiation into insulin-sensitive and insulin-insensitive types. Lancet 1, 127-130.
41. Holmes A, Murphy DL, Crawley JN (2002). Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berlin) 161, 160-167.
42. Holmes A, Murphy DL, Crawley JN (2003a). Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biological Psychiatry 4, 953-959.
43. Holmes A, Yang RJ, Lesch KP, Crawley JN, Murphy DL (2003b). Mice lacking the serotonin transporter exhibit 5-HT1A receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 28, 2077-2088.
44. Holsboer F (2000). The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23, 477-501.
45. Kendler KS, Kuhn J, Vittum J, Prescott CA, Riley B (2005). The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Archives of General Psychiatry 62, 529-535.
46. Lee MS, Lee HY, Lee HJ, Ryu SH (2004). Serotonin transporter promoter gene polymorphism and long-term outcome of antidepressant treatment. Psychiatric Genetics 14, 111-115.
47. LeRoith D (2002). Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities. American Journal of Medicine 113 (Suppl. 1), 3-11.
48. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531.
49. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C (1988). Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. New England Journal of Medicine 318, 1217-1225.
50. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH, Bradley-Moore M, Lira J, Underwood MD, Arango V, et al. (2003). Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biological Psychiatry 54, 960-971.
51. Lopez JF, Chalmers DT, Little KY, Watson SJ (1998). A.E. Bennett Research Award. Regulation of Serotonin 1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biological Psychiatry 43, 547-573.
52. Lowther S, De Paermentier F, Cheetham SC, Crompton MR, Katona CL, Horton RW (1997). 5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. Journal of Affective Disorders 42, 199-207.
53. Maj J, Klimek VJ, Nowak G (1985). Antidepressant drugs given repeatedly increase binding to alpha 1-adrenoceptors in the rat cortex. European Journal of Pharmacology 119, 113-116.
54. 123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl) tropane and single photon emission computed tomography. Biological Psychiatry 44, 1090-1098.
55. Mann JJ (1999). Role of the serotonergic system in the pathogenesis of major depression and suicide. Neuropsychoparmacology 21, 99S-105S.
56. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, Dwork AJ, Arango V (2000). A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Archives of General Psychiatry 57, 729-738.
57. Martin FI, Wyatt GB, Gripe AR, Haurahelia M, Higginbotham L (1980). Diabetes mellitus in urban and rural communities in Papua, New Guinea: studies of prevalence and plasma insulin. Diabetologia 18, 369-374.
58. Maswood S, Barter JE, Watkins SF, Maier SF (1998). Exposure to inescapable but not escapable shock increases extracellular levels of 5-HT in the dorsal raphe nucleus of the rat. Brain Research 783, 115-120.
59. Matsubara S, Arora RC, Meltzer HY (1991). Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims. Journal of Neural Transmission 85, 181-194.
60. Meltzer CC, Price JC, Mathis CA, Butters MA, Ziolko SK, Moses-Kolko E, Mazumdar S, Mulsant BH, Houck PR, Lopresti BJ, et al. (2004). Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 29, 2258-2265.
61. Messa C, Colombo C, Moresco RM, Gobbo C, Galli L, Lucignani G, Gilardi MC, Rizzo G, Smeraldi E, Zanardi R, et al. (2003). 5-HT2A receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Psychopharmacology (Berlin) 167, 72-78.
62. 11)C]DASB PET imaging study. American Journal of Psychiatry 158, 1843-1849.
63. Murphy GM, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF (2004). Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Archives of General Psychiatry 61, 1163-1169.
64. Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA, Eckelman W, Herscovitch P, Charney DS, Drevets WC (2004). Reduced serotonin type 1A receptor binding in panic disorder. Journal of Neuroscience 24, 589-591.
65. Ostlund H, Keller E, Hurd YL (2003). Estrogen receptor gene expression in relation to neuropsychiatric disorders. Annals of the New York Academy of Sciences 1007, 54-63.
66. Overstreet DH, Janowsky DS, Pucilowski O, Rezvani AH (1994). Swim test immobility co-segregates with serotonergic but not cholinergic sensitivity in cross-breds of Flinders Line rats. Psychiatric Genetics 4, 101-107.
67. Owen MJ, Nemeroff CB (1994). Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clinical Chemistry 40, 288-295.
68. Pariante CM, Miller AH (2001). Glucocorticoid reeptors in major depression: relevance to pathophysiology and treatment. Biological Psychiatry 49, 301-404.
69. Parks CL, Robinson PS, Sibille E, Shenk T, Toth M (1998). Increased anxiety of mice lacking the serotonin 1A receptor. Proceedings of the National Academy of Sciences USA 95, 10734-10739.
70. Parsey RV, Hastings RS, Oquendo MA, Huang YY, Simpson N, Arcement J, Huang Y, Ogden RT, Van Heertum RL, Arango V, Mann JJ (2006). Lower serotonin transporter binding potential in the human brain during major depressive episodes. American Journal of Psychiatry 163, 52-58.
71. Plaznik A, Stfanski R, Palejko W, Bidzinski A, Kostowski W, Jessa M, Nazar M (1994). Antidepresant treatment and limbic serotonergic mechanisms regulating rat locomotor activity. Pharmacology Biochemistry & Behavior 48, 315-325.
72. Potter WZ (1996). Adrenoceptors and serotonin receptor function: relevance to antidepressant mechanism of action. Journal of Clinical Psychiatry 57 (Suppl. 4), 4-8.
73. Pucak ML, Kaplin AI (2005). Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression. International Review of Psychiatry 17, 477-483.
74. Putzhammer A, Schoeler A, Rohrmeier T, Sand P, Hajak G, Eichhammer P (2005). Evidence of role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment. Psychopharmacology 178, 303-308.
75. Ramboz S, Oosting R, Amara A, Kung HF, Blier P, Mendelson M, Mann JJ, Brunner D, Hen R (1998). Serotonin receptor 1A knockout: an animal model of anxiety related disorder. Proceedings of the National Academy of Sciences of the USA 95, 14476-14481.
76. Ressler KJ, Nemeroff CB (2000). Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depression and Anxiety 12 (Suppl. 1), 2-19.
77. Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, Janssen I (2000). Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Annals of Internal Medicine 133, 92-103.
78. Ross R, Janssen I, Dawson J, Kungl AM, Kuk JL, Wong SL, Nguyen-Duy TB, Lee S, Kilpatrick K, Hudson R (2004). Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obesity Research 12, 789-798.
79. Rueter LE, Fornal CA, Jacobs BL (1997). A critical review of 5-HT brain microdialysis and behavior. Reviews in the Neurosciences 8, 117-137.
80. 11C]WAY-100635: effects of depression and antidepressant treatment. Archives of General Psychiatry 57, 174-180.
81. Schildkraut JJ (1969). Neuropsychopharmacology and the affective disorders [First of three parts]. New England Journal of Medicine 281, 197-201.
82. Senthilvelan M, Ravindran R, Samson J, Devi RS (2006). Serotonin turnover in discrete regions of young rat brain after 24 h REM sleep deprivation. Neurochemical Research 31, 81-84.
83. Shalit M, Yadid G, Overstreet D, Weller A (2003). 5-HT1A receptor subsensitivity in infancy and supersensitivity in adulthood in an animal model of depression. Brain Research 980, 100-108.
84. Sheline YL, Mintun MA, Barch DM, Wilkins C, Snyder AZ, Moerlein SM (2004). Decreased hippocampal 5-HT2A receptor binding in older depressed patients using [18F]altanserin positron emission tomography. Neuropsychopharmacology 29, 235-241.
85. Sher L, Oquendo MA, Li S, Ellis S, Brodsky BS, Malone KM, Cooper TB, Mann JJ (2003). Prolactin response to fenfluramine administration in patients with unipolar and bipolar depression and healthy controls. Psychoneuroendocrinology 28, 559-573.
86. Shively CA, Friedman DP, Gage HD, Bounds MC, Brown-Proctor C, Blair JB, Henderson JA, Smith MA, Buchheimer N (2006). Behavioral depression and positron emission tomography-determined serotonin 1a receptor binding potential in cynomolgus monkeys. Archives of General Psychiatry 63, 396-403.
87. Smits KM, Smits LJ, Schouten JS, Stelma FF, Nelemans P, Prins MH (2004). Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review. Molecular Psychiatry 9, 433-441.
88. Stockmeier CA (2003). Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. Journal of Psychiatric Research 37, 357-373.
89. Stockmeier CA, Dilley GE, Shapiro LA, Overholser JC, Thompson PA, Meltzer HY (1997). Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology 16, 163-173.
90. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G (1998). Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. Journal of Neuroscience 18, 7394-7401.
91. Stokes PE (1995). The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. European Neuropsychopharmacology 5, 77-82.
92. Sullivan GM, Oquendo MA, Simpson N, Van Heertum RL, Mann JJ, Parsey RV (2005). Brain serotonin 1A receptor binding in major depression is related to psychic and somatic anxiety. Biological Psychiatry 58, 947-954.
93. Tanaka M, Nakagawa R, Kohno Y, Ida Y, Hoaki Y, Tsuda A, Nagasaki N, Noda Y (1982). Bilateral adrenalectomy does not alter stress-induced increases in noradrenaline turnover in rat brain regions. Kumamoto Medical Journal 29, 173-178.
94. Tjurmina OA, Armando I, Saavedra JM, Goldstein DS, Murphy DL (2002). Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene. Endocrinology 143, 4520-4526.
95. Van Riel E, Meijer OC, Steenbergen PJ, Joels M (2003). Chronic unpredictable stress causes attenuation of serotonin responses in cornus ammonis 1 pyramidal neurons. Neuroscience 120, 649-658.
96. Wallis E, Overstreet DH, Crocker AD (1988). Selective breeding for increased cholinergic function: increased serotonergic sensitivity. Pharmacology Biochemistry and Behavior 31, 345-350.
97. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR (1990). Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic patients. Annals of Internal Medicine 113, 909-915.
98. 123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biological Psychiatry 47, 482-489.
99. Zangen A, Nakash R, Overstreet DH, Yadid G (2001). Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens. Psychopharmacology 155, 434-439.
100. Zangen A, Overstreet G, Yadid G (1997). High serotonin and 5-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment. Journal of Neurochemistry 69, 2477-2483.